Home
Pipeline&Products
Science&Innovation
Recombinant IgG Cleaving Enzyme
Recombinant Human Hyaluronidase
Solutions
Investor Relations
Listing documents
Announcement and Circular Letter
Performance Report
Corporate Governance
Investor Contact
Media
About Us
Our Stories
Join Us
Contact Us
简
繁
EN
Home
Pipeline&Products
Science&Innovation
Recombinant IgG Cleaving Enzyme
Recombinant Human Hyaluronidase
Solutions
Media
About Us
Our Stories
Join Us
Contact Us
Investor Relations
Listing documents
Announcement and Circular Letter
Performance Report
Corporate Governance
Investor Contact
简
繁
EN
请输入您要查找的信息
热门关键词：
透明质酸酶
皮下给药
Announcement and Circular Letter
Responding to urgent patient needs
Innovating for diverse health challenges
Listing documents
Announcement and Circular Letter
Performance Report
Announcement and Circular Letter
2026.01.16
Notification Letter and Reply Form to Registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications
2026.01.16
Notification Letter and Reply Form to Non-registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications
2026.01.05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025
2025.12.30
INSIDE INFORMATION - PROPOSED IMPLEMENTATION OF H SHARE FULL CIRCULATION PROGRAM BY THE COMPANY
2025.12.09
ANNOUNCEMENT OF FINAL OFFER PRICE AND ALLOTMENT RESULTS
2025.12.09
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2025.12.09
Terms of Reference for the Nomination Committee of the Board of Directors
2025.12.09
Terms of reference for the Remuneration Committee of the Board of Directors
«
1
2
»
